Electromed (ELMD) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- S&P Global explores potential separation of Capital IQ business
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Electromed, Inc. Announces Fiscal 2023 Third Quarter Results
May 9, 2023 4:05 PM EDTQuarterly Net Revenue Increase of 19% Year-over-Year
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (Electromed) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2023 (Q3 FY 2023).
Q3 FY 2023 Highlights
Record quarterly net revenues of $12.1 million, a 19% year-over-year increase Homecare revenue of $11.0 million, an increase of 21% year-over-year Generated operating income of $1.2 million, an increase of 39% year-over-year Net income of $1.1 million, or $0.12 per fully diluted share, compared with net... More


